889 / 1161
Summary
Radiation Oncology is being revolutionized by new technologies and
those are crucially dependent on imaging
Prerequisites for changing concepts are a clinical need and the
superiority of the new imaging to traditional methods and may vary
significantly between tumors, tracers and clinical scenarios
To seriously show patients benefit by the use of new imaging
modalities in different clinical situations, clinical trials are
mandatory
Beyond target volume definition, other areas of the use of hybrid
imaging in radiotherapy (response assessment, NT-monitoring …)
are presently being investigated